Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-02 · accession 0001140361-23-023022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-04 | 2023-05-02 | FDMT | Kirn David | CEO, Dir | G - Gift | $0.00 | -600.0K | 1.26M | -32% | $0 | |
| I | 2023-05-04 | 2023-05-02 | FDMT | Kirn David | CEO, Dir | G - Gift | $0.00 | +600.0K | 600.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-02 | G | D | 600,000 | $0.00 | 1,259,153 | D Family Trusts | — | — | |
| 2 | Common | Common Stock | 2023-05-02 | G | A | 600,000 | $0.00 | 600,000 | I | — | — |